Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023 16:05 ET
|
Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
Social Life Network Announces Name Change on OTC Markets to Decentral Life, Inc.
February 03, 2023 13:11 ET
|
Decentral Life, Inc
GREENWOOD VILLAGE, CO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Decentral Life, Inc. (OTC: WDLF), a Technology Business Incubator (TBI), previously named Social Life Network, Inc., is pleased to announce...
Social Life Announces Record Growth in 2022, Topping 300% Increase in Annual Sales
January 06, 2023 11:35 ET
|
Social Life Network, Inc.
significantly increased its annual sales by 318% year-over-year from 2021 while holding operating expenses in line with 2021 has significantly increased operating income for 2022 LOS ANGELES, CA,...
Aviv Clinics and America’s Mighty Warriors Partner to Provide Life-Changing Treatments to Veterans Suffering from Concussion, Traumatic Brain Injury
November 11, 2022 09:12 ET
|
Aviv Clinics
ORLANDO, Fla., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Aviv Clinics, the global leader in the research and treatment of brain conditions, today announces a pledge of $1 million in in-kind treatments to...
Endonovo Therapeutics Releases Comparative Analysis Demonstrating
July 28, 2022 09:08 ET
|
Endonovo Therapeutics, Inc.
More Effective SofPulse® Results Compared With Bioelectronics RecoveryRx® Los Angeles, CA, July 28, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today released superior...
Constant Therapy Announces Publication of Study Demonstrating Improved Outcomes for Post-Stroke Patients Using Its Digital Speech, Language, and Cognitive Therapy
July 20, 2022 10:46 ET
|
Constant Therapy Health
LEXINGTON, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Constant Therapy Health, a brain health digital therapeutics company, announced today the publication of a dosage study in the Journal of Medical...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TrueBlue, Inc. Investors to Inquire About Securities Class Action Investigation – TBI
July 05, 2022 12:43 ET
|
The Rosen Law Firm PA
NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of TrueBlue,...
Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug
June 29, 2022 08:30 ET
|
Odyssey Health, Inc
Las Vegas, NV, June 29, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
(TBI): Johnson Fistel, Globally-Recognized Law Firm, Investigates TrueBlue After CEO Resignation
June 16, 2022 09:42 ET
|
Johnson Fistel, LLP
SAN DIEGO, June 16, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether TrueBlue, Inc. (NYSE: TBI), any of its executive...
Endonovo Therapeutics Announces LOI to Acquire Specialty Construction Company
June 09, 2022 14:02 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, June 09, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB:ENDV) today announced a Letter of Intent to purchase a highly-regarded market leading specialty concrete services...